Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Jul 3, 2013
Insider Transaction Report
Form 4
Dunlap Ryan
Principal Accounting Officer
Transactions
- Other
Common Stock, par value $0.0001
2013-06-30$1.35/sh+1,369$1,848→ 2,615 total
Footnotes (1)
- [F1]Pursuant to the Issuer's Employee Stock Purchase Plan.